Monoclonal antibodies in sepsis and septic shock.
- 18 January 1992
- Vol. 304 (6820), 132-133
- https://doi.org/10.1136/bmj.304.6820.132
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Treatment of Gram-negative septic shock with an immunoglobulin preparationCritical Care Medicine, 1991
- Antibodies to Lipopolysaccharides after Immunization of Humans with the Rough Mutant Escherichia coli J5The Journal of Infectious Diseases, 1991
- Antibodies to Core Lipopolysaccharide Determinants: Absence of Cross-reactivity with Heterologous LipopolysaccharidesThe Journal of Infectious Diseases, 1991
- Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndromeCritical Care Medicine, 1990
- Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.The Journal of Experimental Medicine, 1990
- Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.The Journal of Experimental Medicine, 1990
- Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized TrialThe Journal of Infectious Diseases, 1988
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPIDThe Lancet, 1985
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982